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Abstract 
Introduction: Neurofibromatosis is a genetic disease characterized by multifocal benign tumors of 
peripheral nerves, called neurofibromas, and pigmented spots on the skin which inherited as 
autosomal-dominant. The most common form of the disease is neurofibromatosis type 1, also 
known as von Recklinghausen's disease of the skin. When an individual has small number of 
lesions in a limited region of the his body, it could be missed by the patient or not acknowledged 
by the clinicians as a form of neurofibromatosis. We present here, a case of an 18-year-old male 
with neurofibromatosis type 1who referred to Babol Dental School for a routine dental 
examination. 
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سيزوتاموربيفورون زا یدروم شراسگ 
فن اميشهدازر* ،ولتعامج همغن ،ینابرق اتيهانآ ،داصن بلطم انيم 
 
هديکچ  
همدقم: دذعتم ميخ شًخ یاَرًمًت یاراد نايلاتثم ٍک تسا یکيتوش یراميت کي سيزًتاميرثيفيرًو  ٍت یطيحم باصعا
ي اميرثيفيرًو ماو یم تسًپرد ٍواذگور یاَ ٍکل ثرا ٍت ةلاغ لاميزًتا ترًص ٍت یکيتوش رظو زا .ذىشات  هيرتجيار .ذسر یم
 عًو سيزًتاميرثيفيرًو یراميتزا لکش1 یراميت اي Recklinghausen Von یماگىَ .تسا ٌذش ٍتخاىش تسًپ  ٍک
درف کي داذعت یاراد زا یمک رد تاعياض ديذحم ٍقطىم کي زا ي دريگو رارق ٍجًت درًم تسا هکمم ،ذشات نذت اي  طسًت
رد .دًشو ٌداد صيخشت ناکشسپ اجىيا یدرًم  رسپ کي زا11  عًو سيزًتاميرثيفيرًو ٍت لاتثم ٍلاس1  ٍىياعم یارت ٍک
دًش یم شراسگ ،تسا ٌدرک ٍعجارم لتات یکشسپواذود ٌذکشواد ٍت یکشسپواذود لًمعم . 
 :یديلک ناگشاو،اميرثيفيرًو ،سيزًتاميرثيفيرًو درًم شراسگ 
 
Introduction 
Neuorofibroma is a benign slow growing tumor 
(1) .It is the most common neoplasm in peripheral 
nervous system, originating from “Schwann cells” and 
perineural fibroblasts (2). This neoplasm may manifest 
as a solitary nodule or as a generalized syndrome called 
Neuorofibromatosis or Von Recklinghausen disease 
(1). However, neurofibroma is a common neurogenic 
tumor, it is rare in oral cavity (3) and skin is the most 
common region of involvement (4-8).  
It is usually seen in the 3
rd
 decade of life without 
any sex predilection (5). Clinically neurofibroma is a 
pedunculated or sessile slow growing nodule in oral 
cavity. It is usually painless, but pain and parasthesia 
may occur due to nerve compression.  
Tongue is the most frequent region of intraoral 
involvement, but it may be seen in other regions such 
as palate, buccal mucosa and floor of the mouth (9-11). 
Cases of mandibular bone involvement have been 
reported (12-15).  
At least eight different form of neurofibromatosis 
is known and type I is the most common form. In this 
type, patients suffer from several neurofibromas, Skin 
is the most common affected site. Any organs maybe 
affected. Tumors may be present at birth or maybe seen  
first at adolescent and grow gradually and slowly.  
Hyperpigmentation in skin, called café au lait macules 
and macules on the axilla or the groin regions (crave’s 
sign) are the pathognomonic signs of the disease. Lisch 
nodules in iris are seen in all affected patients (2).  
Here, we report a case of Neurofibromatosis type I 
with cutaneous and oral lesions.  
 
Case report 
An 18 year old male with no history of any 
specific disease and alcohol or nicotine consumption 
referred to the Oral Medicine Department of Babol 
University of Medical Sciences for routine dental 
examination. We found a soft, sessile, exophytic mass 
with pink homogenous color and fluctuant in texture, 
located in his hard palate, approximately 2 x 1.6 cm 
(figure 1). In radiographic examination, we found no 
abnormal changes. We found several subcutaneous 
nodules on his hand and trunk and 4-5 café au lait 
macules were seen in his thoracic region (figure 2). An 
incisional biopsy of the hard palate mass was done. On 
gross examination, 2 pieces of triangular, firm and 
creamy tissues covered by oral mucosa, measured 
0.8×0.7×0.2 cm, were seen. 
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Figure 1. Clinical view of the patient's oral lesion 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Clinical view of subcutaneous nodules and 
café au lait macules on the patient' trunk 
 
The microscopic examination revealed a tumor 
that composed of spindle shaped cells with wavy nuclei 
scattered in a fibrous to myxoid stroma (figure 3 and 4). 
Neurofibroma, neurilemmoma and palisaded 
encapsulated neuroma can be considered as differential 
diagnoses. Considering the whole microscopic 
features, neurofibroma was rendered as the 
histopathologic diagnosis and also, neurofibromatosis 
was described as the final diagnosis based on 
combining clinical and microscopic findings. 
 
 
 
 
 
 
 
 
 
 
Figure 3. Microscopic view showing some sections 
of neurons and spindle shaped cells with wavy 
nuclei scattered in a fibrotic stroma 
(H&E staining; x 100) 
 
 
 
 
 
 
 
 
 
 
Figure 4. Microscopic view showing spindle shaped 
cells with wavy nuclei scattered in a myxoid stroma 
(H&E staining x 400) 
 
 
Discussion 
The symptoms of neurofibromatosis have been 
observed for a long time before Robert William Smith 
described it in 18491 (16). The classic variety is the 
one which German pathologist, Friedrich Daniel von 
Recklinghausen reported, who precisely described the 
diverse findings as a single entity in 1882; so the 
condition is often directed to as von Recklinghausen’s 
disease (17).  
On the basis of the most widely accepted 
classification, there are four recognized forms of 
neurofibromatosis: von Recklinghausen’s 
neurofibromatosis (or neurofibromatosis type 1 [NF-1] 
or peripheral neurofibromatosis). Bilateral acoustic 
neurofibromatosis (or neurofibromatosis type 2 [NF-2] 
or central neurofibromatosis). 
Segmental neurofibromatosis cutaneous 
neurofibromatosis (17). Advances in molecular 
genetics have produced a sharp delineation between, 
the variants of NF. NF-1 has been related to alterations 
in the long arm of chromosome 17 (18-23), 
characterized by the formation of tumors surrounding 
the nerves and a variety of other pathological features (17).  
In childhood or early adolescence, the 
characteristic clinical features would be apparent (21, 
24). NF-1 which is the most common type accounts for 
90% of cases and is characterized by multiple café-au-
lait spots and the incidence of neurofibromas along 
peripheral nerves (17).  
Café–au-lait discoloration generally emerge before 
the development of neurofibromas and their amounts 
increase with age (25). Cutaneous neurofibromas are 
soft, fleshy -pink colored tumors, most enormous on 
the trunk and limbs as sessile or dome-shaped masses. 
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Other clinical aspects contain Lisch’s nodules 
(melanocytic pigmented iris hamartomas) and oral 
lesions (17).  
Although bilateral Lisch’s nodules are indicative 
of the disease, they are not quit diagnostic (26). 
Possible childhood complexities contain the optic 
glioma growth, endocrine disturbances and entailment 
of the lower urinary tract. Learning disabilities may 
also be presented in children (17). For all cases, 
histopthologic examination is needed.  
It is important to mention that numerous variants 
of the classic neurofibroma may be seen in the oral 
cavity (i.e.1-classic neurofibroma, 2-plexiform 
neurofibroma or neuroma, 3-the pseudo-schwannoma 
form of neurofibroma, 4-hemangioneurofibroma) (27).  
For diagnosing NF-1, at least two of the below 
criteria must be present according to the National 
Institute of Health Consensus Development 
Conference (28). 
1. Five or more cafe-au-lait spots larger than 5 mm in 
diameter in prepubertal patients; six or more  
cafe-au-lait spots larger than 15 mm in diameter in 
postpubertal patients 
2. Two or more neurofibromas of any type, or one 
plexiform neurofibroma 
3. Axillary or inguinal freckling 
4. Optic glioma 
5. Two or more Lisch’s nodules (iris hamartomas) 
6. A distinctive osseous lesion (pseudoarthrosis of the 
tibia or sphenoid wing dysplasia) 
7. A first-degree relative diagnosed (17). 
The patient, presented here, had multiple tumors 
on his arms and trunk other than the one existed on his 
hard palate; so we referred him to compatible centers 
for treatment. He did not respond to our calls for 
following up his treatment procedure. 
 
 
Conclusions 
The patient described here is a very typical case of 
NF-1. In such a case, a detailed patient investigation is 
required because of the possibility for generalized 
involvement of other organs.  
The proper clinical and genetic analysis is 
important for the determination of the genetic risk and 
evaluation of the prognosis of the disease. The 
treatment of such kind of patient is surgery, seeking to 
achieve cosmetic improvement, and may be only 
palliative (17). 
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